Official Full Name
Levansucrase
Background
Levansucrase (EC 2.4.1.10) is an enzyme that catalyzes the chemical reaction: sucrose + (2,6-beta-D-fructosyl)n → glucose + (2,6-beta-D-fructosyl)n+1. Thus, the two substrates of this enzyme are sucrose and (2,6-beta-D-fructosyl)n, whereas its two products are glucose and (2,6-beta-D-fructosyl)n+1. This enzyme belongs to the family of glycosyltransferases, specifically the hexosyltransferases.
Synonyms
Levansucrase; EC 2.4.1.10; sucrose:2#6-beta-D-fructan 6-beta-D-fructosyltransferase; sucrose 6-fructosyltransferase; beta-2#6-fructosyltransferase; beta-2#6-fructan:D-glucose 1-fructosyltransferase
Introductions
Levansucrase is an enzyme belonging to the glycoside hydrolase family that catalyzes the hydrolysis of sucrose to glucose and fructose and the synthesis of fructose polymers from sucrose. This enzyme belongs to the family of glycosyltransferases, particularly hexosyltransferases. Levansucrase has a wide range of applications in various industries such as food, beverage and biotechnology.
Figure 1. Structure of levansucrase.
Classes
Levansucrases can be classified according to their sequence similarity and biochemical properties. There are two main classes of levansucrases: bacterial and phytoLevansucrases. Bacterial levansucrases are usually found in Gram-negative bacteria, whereas plant levansucrases are found in higher plants, such as dandelion and chicory.
Function
The function of levansucrase depends on its specific application. In general, levansucrase can be used to synthesize fructose, a probiotic compound that promotes the growth of beneficial intestinal bacteria. levansucrase can also be used to produce high fructose syrup, a sweetener widely used in the food industry. In addition, levansucrase can be used to synthesize levan, a fructose polymer used as a drug delivery system in the pharmaceutical industry.
Mechanism
The mechanism of levansucrase involves several steps. First, the enzyme binds to sucrose and cleaves it to glucose and fructose. Next, fructose molecules are transferred to the growing fructan chains, which are formed by the polymerization of fructose molecules. This process continues until the desired fructose chain length is reached. Levansucrase can also perform the reverse reaction, which hydrolyzes the fructose polymer to release the fructose monomer. The balance between the synthesis and hydrolysis reactions can be controlled by adjusting the reaction conditions (e.g. pH and temperature).
Applications
-
Food and beverage industry: Levansucrase can be used to produce high fructose syrup, a sweetener widely used in the food industry. It can also be used to synthesize fructose, a probiotic compound that promotes the growth of beneficial intestinal bacteria.
-
Biotechnology: Levansucrase can be used to synthesize levan, a fructan polymer that is used as a drug delivery system in the pharmaceutical industry. It can also be used to produce fructan polymers for use in biocomposites and biomaterials.
-
Agriculture: Levansucrase is produced by many plant species and it plays a role in plant defense against pathogens. It has been shown to enhance the resistance of crops to fungal infections, such as wheat, barley and tomatoes.
Clinical significance:
The clinical significance of levansucrase is limited due to its primary use for industrial applications. However, several studies have investigated the potential therapeutic applications of fructans and high fructose syrups produced using levansucrase. Fructans produced by levansucrase have a probiotic effect on the gut microbiome, leading to improved gut health and immune function in animal models. Further studies are needed to fully understand the potential benefits and risks of using levansucrase-derived products in a clinical setting.
Conclusion
Levansucrase has a wide range of applications in various industries, such as food, beverage and biotechnology. levansucrase has limited clinical relevance, but several studies have investigated the use of levansucrase produced fructose and high fructose syrup for potential therapeutic applications. Further studies are needed to fully understand the potential benefits and risks of using levansucrase-derived products in the clinical setting.